Botox maker Allergan rejected Actavis takeover bid

Pharmaceutical company Actavis recently made a bid for Allergan, but the Botox maker rejected the proposal and is closing in on its own takeover, The Wall Street Journal reports.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.